This clinical validation study evaluated a blood-based multi-cancer early detection (MCED) test that analyzes cell-free DNA (cfDNA) methylation patterns using targeted sequencing and machine learning. Conducted as part of the CCGA study, the analysis included 4,077 participants (2,823 with cancer, 1,254 without). The test achieved a specificity of 99.5% and
